How many insider trades does FilingIQ track for EOLS?

FilingIQ tracks 248 Form 4 insider transactions for EOLS (Evolus, Inc.), covering filings from Feb 12, 2018 onwards. 22 of those were filed in the last 90 days.

Are EOLS insiders net buyers or net sellers?

Across the full Form 4 history for EOLS, 45 transactions (18%) were open-market purchases and 99 (40%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does EOLS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is EOLS in?

Evolus, Inc. (EOLS) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $314.24M.

EOLS insider trading

NasdaqGM Healthcare

Evolus, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

248

Last 90 days

Buys / sells

18% / 40%

Market cap

$314.24M

About Evolus, Inc.

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Company website: www.evolus.com

EOLS insider activity at a glance

FilingIQ has scored 248 insider transactions for EOLS since Feb 12, 2018. The most recent filing in our index is dated Mar 20, 2026.

Across the full history, 45 open-market purchases and 99 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on EOLS insider trades is 52.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live EOLS trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding EOLS

PERCEPTIVE ADVISORS LLC

$49.67M · 1.8% of AUM

Nantahala Capital Management, LLC

$31.58M · 1.8% of AUM

Frequently asked

How many insider trades does FilingIQ track for EOLS?: FilingIQ tracks 248 Form 4 insider transactions for EOLS (Evolus, Inc.), covering filings from Feb 12, 2018 onwards. 22 of those were filed in the last 90 days.
Are EOLS insiders net buyers or net sellers?: Across the full Form 4 history for EOLS, 45 transactions (18%) were open-market purchases and 99 (40%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does EOLS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is EOLS in?: Evolus, Inc. (EOLS) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $314.24M.

Methodology & sources

Every EOLS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.